Title of article :
Synthesis and structure–activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase Original Research Article
Author/Authors :
Karen L. Milkiewicz، نويسنده , , Linda R. Weinberg، نويسنده , , Mark S. Albom، نويسنده , , Thelma S. Angeles، نويسنده , , Mangeng Cheng، نويسنده , , Arup K. Ghose، نويسنده , , Renee C. Roemmele، نويسنده , , Jay P. Theroff، نويسنده , , Ted L. Underiner، نويسنده , , Craig A. Zificsak، نويسنده , , Bruce D. Dorsey، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2010
Pages :
12
From page :
4351
To page :
4362
Abstract :
Dysregulation of the anaplastic lymphoma kinase (ALK) is implicated in a variety of cancers. A series of tetrahydropyrido[2,3-b]pyrazines was constructed as ring-constrained analogs of a known aminopyridine kinase scaffold. Chemistry was developed to rapidly elaborate the SAR, structural elements impacting ALK inhibitory activity were exploited, and kinase selective analogs were identified that inhibit ALK with IC50 values ∼10 nM (enzyme) and ∼150 nM (cell).
Keywords :
Anaplastic lymphoma kinase , Kinase inhibitors
Journal title :
Bioorganic and Medicinal Chemistry
Serial Year :
2010
Journal title :
Bioorganic and Medicinal Chemistry
Record number :
1306551
Link To Document :
بازگشت